IOVA
IOVA
US4622601007
Iovance Biotherapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 263.502.000 164.070.000
60.6%
Cost of Revenue 173.184.000 93.248.000
85.7%
Gross Profit 90.318.000 70.822.000
27.5%
488.531.000 466.100.000
4.8%
Operating Income -398.213.000 -395.278.000
0.7%
Pretax Income -393.049.000 -375.005.000
4.8%
Net Income Common Stockholders -390.978.000 -372.177.000
5.1%
-- --
--
-- --
--
ende